Key advantages: • Understand effective pricing and reimbursement strategies • Gain insight on the role of parallel trade and its effect on pricing policy • Receive an update on global P&R developments, with focus on specific markets around the world • Explore how UK pricing is different from the rest of Europe • Insights into the market access strategies for oncology and CNS products • Assess the cost effectiveness analysis of healthcare technologies • Analyse the impact of global financial crisis on market access opportunities • Be part of a unique networking opportunity

Key Speakers

• Myriam Zylberman, Director Pricing Reimbursement Access and New Products, Lilly • Oliver Mast, Head Global Reimbursement, Roche • Konstantinos Lykopoulos, Manager, Global Health Outcomes – Oncology, GlaxoSmithKline • Dr. Elisabeth George, Associate Director – Appraisals, National Institute for Health and Clinical Excellence • Sarah Pitluck, Director, Coverage & Reimbursement Policy, Government Affairs, Genentech • Herve Lilliu, Senior Director, Outcomes and Access, UCB • Leslie Galloway, Chairman, Ethical Medicines Industry Group • Trevor Leighton, VP Pricing & Reimbursement, Shire • Janice Haigh , European Price and Trade Director, Astellas • Cyrus Chowdhury, Management Consultant, Insight Strategy Advisors • George Wyatt, Managing Director, Wyatt Health Management • Dirk Kars, Partner, Simon-Kucher & Partners • Prof. Mondher Toumi, Chief Scientific Officer, Creativ-Ceutical